Project Details
Description
A Phase 1/2 Open-Label, Single Ascending Dose Trial of a Self-Complementing Optimized Adenoassociated Virus Serotype 8 Factor IX Gene Therapy (AskBio009) in Adults with Hemophilia B
| Status | Finished |
|---|---|
| Effective start/end date | 5/30/12 → 5/30/17 |
Funding
- ASKLEPIOS BIOPHARMACEUTICAL, INC
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.